Showing results (261-270 of 2,337) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|May 28, 2018
Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass NoduleHang Su, Chenyang Dai, Huikang Xie, et al.
Clinical Lung Cancer|May 16, 2018
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung CancerAlexander L Chin, Kiran A Kumar, Haiwei H Guo, et al.
Clinical Lung Cancer|June 11, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective StudyMarisa A Bittoni, Ashwini Arunachalam, Haojie Li, et al.
Clinical Lung Cancer|June 5, 2018
A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study ProtocolYoshihito Kogure, Hideo Saka, Yuichi Takiguchi, et al.
Clinical Lung Cancer|June 5, 2018
Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid TumorsD Ross Camidge, Lecia V Sequist, Pasi A Jänne, et al.
Clinical Lung Cancer|July 9, 2017
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary FibrosisKohei Otsubo, Junji Kishimoto, Hirotsugu Kenmotsu, et al.
Clinical Lung Cancer|June 2, 2018
A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study ProtocolNobukazu Fujimoto, Keisuke Aoe, Toshiyuki Kozuki, et al.
Clinical Lung Cancer|April 19, 2018
The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?Terence T Sio, Anussara Prayongrat, Yun Zhang, et al.
Clinical Lung Cancer|March 18, 2009
Exosomal microRNA: a diagnostic marker for lung cancerGuilherme Rabinowits, Cicek Gerçel-Taylor, Jamie M Day, et al.
Clinical Lung Cancer|March 18, 2009
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expressionRoberta Bartolucci, Jia Wei, Jose Javier Sanchez, et al.
Pageof 234